Vertex Pharmaceuticals | VRTX - 普通股股本

金融业

USD 508.99

USD 27.42B

现金及等价物

USD 7.85B

USD 489.2M

USD 12.54B

USD 3.94B

USD 1.98B

USD 1.27B

USD 1.33B

6.1K

EPS每股收益

USD 4.73

股本和储备

USD 20.25B

USD 2.84B

债务利息支出

USD 3.3M

USD 120.6M

USD 106.7M

USD 131.68B

USD 1.1B

USD 2.07B

USD 1.27B

普通股股本

USD 253.3M

28.05

USD 1.39B

USD 3.33B

销售和管理费用

USD 582.2M

USD 1.77B

贸易债权人

USD 3.61B

应收帐款人

USD 2.13B

	普通股股本	更改		日
AbbVie	USD 1.77B		1.75B	2025-06
Acadia Pharmaceuticals	USD 171.09M		1.9M	2026-03
Agios Pharmaceuticals	USD 59.34M		892K	2026-03
Alnylam Pharmaceuticals	USD 133.73M		290K	2026-06
Amgen	USD 541M		1000K	2026-06
Arrowhead Research	USD 141.14M		564K	2026-06
Biogen	USD 146.7M		200K	2025-09
BioMarin Pharmaceutical	USD 193.54M		267K	2026-06
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Gilead Sciences	USD 1.24B		1000K	2026-06
Incyte	USD 200.98M		1.03M	2026-06
Insmed	USD 218.28M		1.76M	2026-06
Ionis Pharmaceuticals	USD 165.64M		265K	2026-06
J&J	USD 2.41B		1.64M	2026-06
Merck	USD 2.47B		4.93M	2026-03
Moderna	USD 391M		2M	2025-09
Neurocrine Biosciences	USD 100.55M		50K	2026-06
Novartis	USD 1.9B		7.38M	2026-06
Pfizer	USD 5.7B		0	2026-06
PTC Therapeutics	USD 82.88M		1.41M	2026-03
Puma Biotechnology	USD 5K		0	2024-06
Regeneron Pharmaceuticals	USD 105M		300K	2026-03
Roche Holding	CHF 796.77M		1.15M	2026-06
Sanofi	EUR 1.21B		8.25M	2026-03
Sarepta Therapeutics	USD 105.62M		53K	2026-06
Ultragenyx Pharmaceutical	USD 98.3M		1.7M	2026-03
United Therapeutics	USD 42.68M		521K	2026-06
Vertex Pharmaceuticals	USD 253.3M		900K	2026-06